Universal Clinical Codes & Terminology Search

Oncology (minimal residual disease [MRD]) genomic sequence analysis cell-free DNA whole blood subsequent assessment with comparison to initial assessment to evaluate for MRD

Anatomic guide 3D-printed and designed from image data set(s); each additional anatomic guide (List separately in addition to code for primary procedure)

Oncology (solid tumor) targeted genomic sequence analysis 33 genes detection of single-nucleotide variants (SNVs) insertions and deletions copy-number amplifications and translocations in human genomic circulating cell-free DNA plasma reported as presence of actionable variants

Evacuation of meibomian glands using heat delivered through wearable open-eye eyelid treatment devices and manual gland expression bilateral

Infectious disease (bacterial and/or viral respiratory tract infection) pathogen-specific nucleic acid (DNA or RNA) 11 viral targets and 4 bacterial targets qualitative RT-PCR upper respiratory specimen each pathogen reported as positive or negative

Oncology chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs) from cultured CSCs and primary tumor cells categorical drug response reported based on percent of cytotoxicity observed a minimum of 14 drugs or drug combinations

Infectious disease (bacterial and/or viral respiratory tract infection) pathogen-specific nucleic acid (DNA or RNA) 10 viral targets and 4 bacterial targets qualitative RT-PCR upper respiratory specimen each pathogen reported as positive or negative

Autologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; tissue harvesting and cellular implant creation

Oncology (hepatocellular carcinoma) next-generation sequencing methylation pattern assay to detect 6626 epigenetic alterations cell-free DNA plasma algorithm reported as cancer signal detected or not detected

Autologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; injection of cellular implant into knee joint including ultrasound guidance unilateral

Oncology (lung) qPCR-based analysis of 13 differentially methylated regions (CCDC181 HOXA7 LRRC8A MARCHF11 MIR129-2 NCOR2 PANTR1 PRKCB SLC9A3 TBR1_2 TRAP1 VWC2 ZNF781) pleural fluid algorithm reported as a qualitative result

Permanent fallopian tube occlusion with degradable biopolymer implant transcervical approach including transvaginal ultrasound

Rare diseases (constitutional/heritable disorders) whole-genome sequence analysis combination of short and long reads for single-nucleotide variants insertions/deletions and characterized intronic variants copy-number variants duplications/deletions mobile element insertions runs of homozygosity aneuploidy and inversions mitochondrial DNA sequence and deletions short tandem repeat genes methylation status of selected regions blood saliva amniocentesis chorionic villus sample or tissue identifica

Introduction of mixture of saline and air for sonosalpingography to confirm occlusion of fallopian tubes transcervical approach including transvaginal ultrasound and pelvic ultrasound

Neurology (dementia) beta amyloid (AB40 AB42 AB42/40 ratio) tau-protein phosphorylated at residue (eg pTau217) neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) by ultra-high sensitivity molecule array detection plasma algorithm reported as positive intermediate or negative for Alzheimer pathology

Transcatheter tricuspid valve repair percutaneous approach; initial prosthesis

Oncology (solid tumor) next-generation sequencing analysis of tumor methylation markers (>20000 differentially methylated regions) present in cell-free circulating tumor DNA (ctDNA) whole blood algorithm reported as presence or absence of ctDNA with tumor fraction if appropriate

Transcatheter tricuspid valve repair percutaneous approach; each additional prosthesis during same session (List separately in addition to code for primary procedure)

Neurology (traumatic brain injury) analysis of glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) immunoassay whole blood or plasma individual components reported with the overall result of elevated or non-elevated based on threshold comparison

Insertion or replacement of implantable cardioverter-defibrillator system with substernal electrode(s) including all imaging guidance and electrophysiological evaluation (includes defibrillation threshold evaluation induction of arrhythmia evaluation of sensing for arrhythmia termination and programming or reprogramming of sensing or therapeutic parameters) when performed